What is MED-LOGICS?
MED-LOGICS, Inc. operates at the intersection of high-precision engineering and clinical ophthalmology. The company specializes in the design and manufacturing of advanced surgical instrumentation, including the ML7 microkeratome and the CataPulse lens removal system. These tools are essential for cataract and LASIK procedures, providing surgeons with the reliability required for high-stakes ocular interventions. Beyond hardware, the firm maintains a robust service infrastructure, offering comprehensive repair and maintenance support for microkeratome systems, which serves as a critical value-add for medical facilities and surgical centers worldwide. Their market position is defined by a commitment to quality control and the integration of donor cornea tissue products, positioning them as a comprehensive partner for ophthalmic surgical suites.
How much funding has MED-LOGICS raised?
MED-LOGICS has raised a total of $353K across 2 funding rounds:
Debt
$150K
Debt
$203K
Debt (2020): $150K with participation from PPP
Debt (2021): $203K led by PPP
Key Investors in MED-LOGICS
PPP
Public-Private Partnership
What's next for MED-LOGICS?
With the successful acquisition of $203K, MED-LOGICS is well-positioned to accelerate its late-stage expansion objectives. The strategic roadmap likely involves deepening its penetration into international markets and potentially diversifying its product pipeline to include next-generation diagnostic or therapeutic tools. As the company transitions through this phase of growth, the focus will remain on optimizing supply chain efficiencies and enhancing the technological efficacy of its core surgical platforms. By maintaining a disciplined approach to capital deployment, MED-LOGICS aims to sustain its competitive advantage in the ophthalmic device landscape, ensuring that its surgical solutions remain the standard for precision and safety in clinical practice.
See full MED-LOGICS company page
